Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L De Munck

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Breast Cancer Research and Treatment|March 25, 2011
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the NetherlandsL de Munck, M Schaapveld, S Siesling, et al.
Breast (Edinburgh, Scotland)|March 20, 2023
The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant womenR R E Dassen, S Pelders, L de Munck, et al.
Breast Cancer (Tokyo, Japan)|November 15, 2021
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I-III breast cancer patientsL S E van Egdom, K M de Ligt, L de Munck, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2018
Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012M C van Maaren, M Lagendijk, M M A Tilanus-Linthorst, et al.
Breast Cancer Research and Treatment|February 19, 2017
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastasesT J A van Nijnatten, J M Simons, M Moossdorff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
TNM classification and the need for revision of pN3a breast cancerT J A van Nijnatten, M Moossdorff, L de Munck, et al.
Breast Cancer Research and Treatment|January 18, 2011
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the NetherlandsJ Ruiterkamp, M F Ernst, L de Munck, et al.
The British Journal of Surgery|April 8, 2020
Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancerA Z de Boer, N A de Glas, P J Marang-van de Mheen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2015
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentM van der Heiden-van der Loo, L de Munck, G S Sonke, et al.
ESMO Open|April 27, 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort studyS W M Lammers, M Meegdes, I J H Vriens, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|March 25, 2011
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the NetherlandsL de Munck, M Schaapveld, S Siesling, et al.
Breast (Edinburgh, Scotland)|March 20, 2023
The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant womenR R E Dassen, S Pelders, L de Munck, et al.
Breast Cancer (Tokyo, Japan)|November 15, 2021
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I-III breast cancer patientsL S E van Egdom, K M de Ligt, L de Munck, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2018
Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012M C van Maaren, M Lagendijk, M M A Tilanus-Linthorst, et al.
Breast Cancer Research and Treatment|February 19, 2017
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastasesT J A van Nijnatten, J M Simons, M Moossdorff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2017
TNM classification and the need for revision of pN3a breast cancerT J A van Nijnatten, M Moossdorff, L de Munck, et al.
Breast Cancer Research and Treatment|January 18, 2011
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the NetherlandsJ Ruiterkamp, M F Ernst, L de Munck, et al.
The British Journal of Surgery|April 8, 2020
Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancerA Z de Boer, N A de Glas, P J Marang-van de Mheen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2015
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentM van der Heiden-van der Loo, L de Munck, G S Sonke, et al.
ESMO Open|April 27, 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort studyS W M Lammers, M Meegdes, I J H Vriens, et al.
Pageof 3